Aromatase inhibitors (AIs) work by blocking oestrogen production, but only work for post-menopausal women. Examples of aromatase inhibitors include anastrozole (Arimidex®), letrozole (Femara®) and exemestane (Aromasin®).
Aromatase inhibitors are not suitable for women who:
- Have not yet reached menopause
- Are in the middle of menopause
- Have temporarily stopped having menstrual periods because of chemotherapy
Aromatase inhibitors are taken as a single tablet every day, usually for 5 years. But, it can be up to 10 years. If you are being treated with an AI, you may be referred to check your vitamin D level and bone mineral density (BMD) tests to monitor your bone mineral density levels, particularly if you are at risk of developing osteoporosis.
Side effects of aromatase inhibitors include stiffness and pain in bones or joints (arthralgia) and increase the risk of osteoporosis, which may increase the risk of bone fractures.